| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10555-007-9109-4 |
| P698 | PubMed publication ID | 18071636 |
| P50 | author | Andrea M. Mastro | Q38325150 |
| Karen M Bussard | Q59681702 | ||
| P2093 | author name string | Carol V Gay | |
| P2860 | cites work | Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis | Q24669710 |
| Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors | Q32024958 | ||
| Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis | Q40400042 | ||
| CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. | Q47810108 | ||
| Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. | Q52832336 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 41-55 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Cancer and Metastasis Reviews | Q2647982 |
| P1476 | title | The bone microenvironment in metastasis; what is special about bone? | |
| P478 | volume | 27 |
| Q37528680 | A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone |
| Q27330270 | A novel microfluidic platform for studying mammalian cell chemotaxis in different oxygen environments under zero-flow conditions |
| Q34112011 | ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone |
| Q34664057 | Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone |
| Q34036039 | Adenosine and bone metabolism |
| Q33620502 | An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer |
| Q26824827 | BMPs and their clinical potentials |
| Q34059738 | Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway |
| Q27693653 | Biology of bone metastases |
| Q38747909 | Biomaterial-enabled delivery of SDF-1α at the ventral side of breast cancer cells reveals a crosstalk between cell receptors to promote the invasive phenotype. |
| Q35150734 | Blood clot formation does not affect metastasis formation or tumor growth in a murine model of breast cancer |
| Q50182712 | Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing. |
| Q38065098 | Bone homeostasis and breast cancer: implications for complex therapy and the maintenance of bone integrity |
| Q37780807 | Bone marrow and pancreatic islets: an old story with new perspectives |
| Q33943576 | Bone marrow endothelium-targeted therapeutics for metastatic breast cancer |
| Q34132305 | Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases |
| Q37316559 | Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis |
| Q34025195 | Bone metastasis: mechanisms and therapeutic opportunities |
| Q38136271 | Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer |
| Q84878929 | Bone targeted therapies in early breast cancer |
| Q36491642 | Bone-targeted therapy for metastatic breast cancer-Where do we go from here? A commentary from the BONUS 8 meeting. |
| Q46295455 | Breast tumors induced by N-methyl-N-nitrosourea are damaging to bone strength, structure, and mineralization in the absence of metastasis in rats |
| Q55474543 | Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts. |
| Q50027179 | Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases |
| Q39837986 | Cancer cell lines release glutamate into the extracellular environment. |
| Q37496849 | Cancer invasion and metastasis: interacting ecosystems. |
| Q37464897 | Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease |
| Q38981296 | Combined treatment with paclitaxel and suramin prevents the development of metastasis by inhibiting metastatic colonization of circulating tumor cells |
| Q43125114 | Curcumin blocks CCL2-induced adhesion, motility and invasion, in part, through down-regulation of CCL2 expression and proteolytic activity. |
| Q41369617 | Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials |
| Q37990849 | Denosumab for the prevention of skeletal-related events in patients with bone metastasis from solid tumor |
| Q36493469 | Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells |
| Q38950545 | Detecting Tumor Metastases: The Road to Therapy Starts Here |
| Q39180907 | Development and characterization of murine models of medulloblastoma extraneural growth in bone |
| Q34485079 | Disseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone |
| Q38781061 | Effect of PI3K/Akt Signaling Pathway on the Process of Prostate Cancer Metastasis to Bone |
| Q39413850 | Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice |
| Q46875972 | Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial |
| Q37660315 | Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function |
| Q57173474 | Engineered 3D Silk-Based Metastasis Models: Interactions Between Human Breast Adenocarcinoma, Mesenchymal Stem Cells and Osteoblast-Like Cells |
| Q39612205 | Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts |
| Q39804089 | Establishment and validation of an in vitro co-culture model to study the interactions between bone and prostate cancer cells |
| Q34152023 | Examining the Metastatic Niche: Targeting the Microenvironment |
| Q37620228 | Expression of Cadherin-17 Promotes Metastasis in a Highly Bone Marrow Metastatic Murine Breast Cancer Model |
| Q36579672 | Extracellular Matrix Rigidity-dependent Sphingosine-1-phosphate Secretion Regulates Metastatic Cancer Cell Invasion and Adhesion |
| Q41904630 | From prostate to bone: key players in prostate cancer bone metastasis |
| Q34222494 | Hedgehog signaling in tumor cells facilitates osteoblast-enhanced osteolytic metastases |
| Q50242957 | High-Throughput Blood- and Lymph-Capillaries with Open-Ended Pores Which Allow the Transport of Drugs and Cells. |
| Q34925978 | Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. |
| Q33409529 | Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion |
| Q26784751 | Imaging of bone metastasis: An update |
| Q27015894 | In vitro models of the metastatic cascade: from local invasion to extravasation |
| Q35838380 | In vivo tibial compression decreases osteolysis and tumor formation in a human metastatic breast cancer model |
| Q34152723 | Individual and combined soy isoflavones exert differential effects on metastatic cancer progression |
| Q27027365 | Infection-induced changes in hematopoiesis |
| Q39511922 | Inhibitory effect of soluble platelet-derived growth factor receptor β on intraosseous growth of breast cancer cells in nude mice |
| Q49583565 | Integrin Alpha V Beta 3 Targeted Dendrimer-Rapamycin Conjugate Reduces Fibroblast-Mediated Prostate Tumor Progression and Metastasis. |
| Q46911164 | Localization of osteoblast inflammatory cytokines MCP-1 and VEGF to the matrix of the trabecula of the femur, a target area for metastatic breast cancer cell colonization |
| Q60949963 | Loss of Myeloid-Specific TGF-β Signaling Decreases CTHRC1 to Downregulate bFGF and the Development of H1993-Induced Osteolytic Bone Lesions |
| Q90401265 | Mechanically-Loaded Breast Cancer Cells Modify Osteocyte Mechanosensitivity by Secreting Factors That Increase Osteocyte Dendrite Formation and Downstream Resorption |
| Q24597798 | Mechanisms of bone metastases of breast cancer |
| Q38367715 | Metabolism and pharmacokinetics of radium-223 in prostate cancer |
| Q91823910 | Metastasis Organotropism: Redefining the Congenial Soil |
| Q29547660 | Microenvironmental regulation of metastasis |
| Q47105411 | Molecular Pathogenesis and Diagnostic Imaging of Metastatic Jaw Tumors |
| Q89587149 | Novel Techniques to Study the Bone-Tumor Microenvironment |
| Q34249263 | Novel therapies for metastatic castrate-resistant prostate cancer |
| Q99551354 | OXPHOS-dependent metabolic reprogramming prompts metastatic potential of breast cancer cells under osteogenic differentiation |
| Q36100749 | Osteoblast-secreted collagen upregulates paracrine Sonic hedgehog signaling by prostate cancer cells and enhances osteoblast differentiation |
| Q64094067 | Osteoblasts are “educated” by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment |
| Q39797043 | Osteoblasts modulate Ca2+ signaling in bone-metastatic prostate and breast cancer cells |
| Q42382543 | Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells |
| Q37187646 | Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments. |
| Q38915494 | Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo. |
| Q38359505 | Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer |
| Q51259345 | Positive Feedback Loops Between Inflammatory, Bone and Cancer Cells During Metastatic Niche Construction. |
| Q56516395 | Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial |
| Q92114995 | Roles of omental and bone marrow adipocytes in tumor biology |
| Q37468577 | Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer |
| Q52337373 | Size Matters: Metastatic Cluster Size and Stromal Recruitment in the Establishment of Successful Prostate Cancer to Bone Metastases. |
| Q93264205 | Small molecule nAS-E targeting cAMP response element binding protein (CREB) and CREB-binding protein interaction inhibits breast cancer bone metastasis |
| Q37848782 | Steps in prostate cancer progression that lead to bone metastasis |
| Q89067481 | Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site |
| Q92138562 | Stress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesis |
| Q55016792 | Stromal cells in breast cancer as a potential therapeutic target. |
| Q38884727 | Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells. |
| Q39995055 | Systemic osteoprotegerin gene therapy restores tumor-induced bone loss in a therapeutic model of breast cancer bone metastasis |
| Q91555177 | Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity |
| Q92081389 | The Bone Extracellular Matrix as an Ideal Milieu for Cancer Cell Metastases |
| Q90339653 | The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis |
| Q64105357 | The Contribution of the Immune System in Bone Metastasis Pathogenesis |
| Q64120685 | The Uncovered Role of Immune Cells and NK Cells in the Regulation of Bone Metastasis |
| Q33874232 | The alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms |
| Q35683552 | The chemokine receptor CX₃CR1 is directly involved in the arrest of breast cancer cells to the skeleton |
| Q41865440 | The clone wars - revenge of the metastatic rogue state: the sarcoma paradigm. |
| Q37808268 | The crossover of bisphosphonates to cancer therapy |
| Q36190094 | The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer |
| Q40548535 | The hedgehog pathway conditions the bone microenvironment for osteolytic metastasis of breast cancer |
| Q30448744 | The role of SPARC in the TRAMP model of prostate carcinogenesis and progression |
| Q39251136 | The use of chemokine-releasing tissue engineering scaffolds in a model of inflammatory response-mediated melanoma cancer metastasis |
| Q58700178 | Three-Dimensional In Vitro Hydro- and Cryogel-Based Cell-Culture Models for the Study of Breast-Cancer Metastasis to Bone |
| Q33862570 | Three-dimensional characterization of the vascular bed in bone metastasis of the rat by microcomputed tomography (MicroCT). |
| Q37641468 | Tumor-stroma co-evolution in prostate cancer progression and metastasis |
| Q34022223 | Tumor-stromal interactions in bone metastasis |
| Q37807047 | Understanding and Optimizing Bone Health in Breast Cancer |
| Q38985672 | Vascular niches for disseminated tumour cells in bone |
| Q44699541 | Walker 256/B malignant breast cancer cells improve femur angioarchitecture and disrupt hematological parameters in a rat model of tumor osteolysis |
| Q89934798 | [Imaging diagnostics in bone metastases] |
| Q35887678 | c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis |
Search more.